Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

101 PGC 005

Next Previous
Drug Profile

101 PGC 005

Alternative Names: 101-PGC-005; 101-PGC-005 ('005)

Latest Information Update: 28 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator 101 Therapeutics
  • Class Antiprotozoals; Antiretrovirals; Antivirals
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II/III COVID 2019 infections
  • Phase I Leishmaniasis
  • Preclinical Dengue; HIV infections; Zika virus infection

Most Recent Events

  • 06 Dec 2024 The US FDA grants Rare Pediatric Disease Designation (RPD) to 101 PGC 005 for the treatment of Juvenile rheumatic arthritis
  • 14 Feb 2023 101 Therapeutics terminates a phase II trial in COVID-2019 infections in Israel due to low enrollment (NCT05195749)
  • 15 Dec 2022 101 PGC 005 is available for licensing as of 15 Dec 2022. https://www.101therapeutics.com/pipeline

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top